Health Insurance and Pharmaceutical Policy Research

New legislative and regulatory initiatives continually shape the US health policy environment.  Policy changes, such as new health insurance benefit limits or expansions, are intended to guard against overuse of health services control costs or improve access and quality of healthcare. However, many new policies are not based on convincing evidence of their efficacy in achieving these objectives.

Over the last two decades, DPM's Division of Health Policy and Insurance Research (HPI) has conducted seminal research evaluating the affordability of health care and medications and the impacts of interventions to improve clinical care or reduce costs.  In addition to publishing the results of these research studies in the medical literature, the group has worked closely with national and state policymakers as well as non-governmental health agencies to translate their research findings into improved health policies.  

More detail on our past research and impacts are available here.  Our current major areas of research focus are described in additional detail at the following links:

Impacts on Domestic Health Policies


Health Insurance Innovation and Health Reform

Pharmaceutical Policy

Affordability and Burden of Medical and Pharmaceutical Costs

Delivery Science

Mental Health Care

Innovative Research Methods

Cancer Policy and Program Evaluation


State and National Health Law and Policy Evaluation

Emerging Topics